Kayne Anderson Rudnick Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Kayne Anderson Rudnick Investment Management's LLY Position: Q1 2026 in Review
Kayne Anderson Rudnick Investment Management reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $10.4M and leaving 71,696 shares worth $65.9M. The position accounts for 0.19% of the portfolio, ranked #110.
Kayne Anderson Rudnick Investment Management first reported a position in LLY in Q2 2019 and has held it in 28 quarters since. The position peaked at $88M in Q4 2025. 4,364 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Kayne Anderson Rudnick Investment Management held 71,696 shares of Eli Lilly worth $65.9M as of Q1 2026.
- Kayne Anderson Rudnick Investment Management sold 10,234 Eli Lilly shares in Q1 2026, an estimated $10.4M.
- Eli Lilly made up 0.19% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #110 holding.
- Kayne Anderson Rudnick Investment Management first reported a position in Eli Lilly in Q2 2019 and has held it in 28 quarters since.
- Kayne Anderson Rudnick Investment Management's Eli Lilly position peaked at $88M in Q4 2025.
- 4,364 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.